Ryan Deschner
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
6
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ryan Deschner
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TRVI Trevi Therapeutics | Initiates: Outperform | $9 | $3.04 | +196.05% | 1 | Aug 30, 2024 | |
| LQDA Liquidia | Upgrades: Strong Buy | $27 | $10.46 | +158.13% | 2 | Aug 19, 2024 | |
| SPRY ARS Pharmaceuticals | Upgrades: Strong Buy | $18 → $22 | $15.20 | +44.74% | 2 | Aug 13, 2024 | |
| OMGA Omega Therapeutics | Initiates: Outperform | $12 | $1.04 | +1,053.85% | 1 | Jun 18, 2024 |
Trevi Therapeutics
Aug 30, 2024
Initiates: Outperform
Price Target: $9
Current: $3.04
Upside: +196.05%
Liquidia
Aug 19, 2024
Upgrades: Strong Buy
Price Target: $27
Current: $10.46
Upside: +158.13%
ARS Pharmaceuticals
Aug 13, 2024
Upgrades: Strong Buy
Price Target: $18 → $22
Current: $15.20
Upside: +44.74%
Omega Therapeutics
Jun 18, 2024
Initiates: Outperform
Price Target: $12
Current: $1.04
Upside: +1,053.85%